Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Miller, Paul S.J.
Andersson, Fredrik L.
and
Kalra, Lalit
2005.
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?.
Stroke,
Vol. 36,
Issue. 2,
p.
360.
Jönsson, Bengt
Carides, George W
Burke, Thomas A
Dasbach, Èrik J
Lindholm, Lars H
and
Dahlöf, Björn
2005.
Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
Journal of Hypertension,
Vol. 23,
Issue. 7,
p.
1425.
Ringleb, Peter A
Schwark, Christian
Schwaninger, Markus
and
Schellinger, Peter D
2005.
Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke.
Expert Opinion on Pharmacotherapy,
Vol. 6,
Issue. 3,
p.
359.
Truelsen, T.
Ekman, M.
and
Boysen, G.
2005.
Cost of stroke in Europe.
European Journal of Neurology,
Vol. 12,
Issue. s1,
p.
78.
Miller, Paul S.J.
Drummond, Michael F.
Langkilde, Lars K.
McMurray, John J.V.
and
Ögren, Mats
2005.
Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation.
European Heart Journal Supplements,
Vol. 7,
Issue. suppl_C,
p.
C41.
Maxhall, Marcus
Backman, Anders
Holmlund, Kenneth
Hedman, Leif
Sondell, Björn
and
Bucht, Gösta
2005.
Responses to a stroke training simulator. A pilot study.
International Journal on Disability and Human Development,
Vol. 4,
Issue. 3,
Lundkvist, J
Ekman, M
Kartman, B
Carlsson, J
Jönsson, L
and
Lithell, H
2005.
The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly.
Journal of Human Hypertension,
Vol. 19,
Issue. 7,
p.
569.
McInnes, G
Burke, T A
and
Carides, G
2006.
Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of Human Hypertension,
Vol. 20,
Issue. 1,
p.
51.
Borg, Sixten
Persson, Ulf
Allikmets, Kristina
and
Ericsson, Karin
2006.
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-Receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: A decision-analytic model.
Clinical Therapeutics,
Vol. 28,
Issue. 11,
p.
1947.
Medin, Jennie
Barajas, Josefin
and
Ekberg, Kerstin
2006.
Stroke patients' experiences of return to work.
Disability and Rehabilitation,
Vol. 28,
Issue. 17,
p.
1051.
Hjelmgren, Jonas
Ghatnekar, Ola
Reimer, Jan
Grabowski, Martin
Lindvall, Olle
Persson, Ulf
and
Hagell, Peter
2006.
Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.
Parkinsonism & Related Disorders,
Vol. 12,
Issue. 7,
p.
443.
Björholt, Ingela
Andersson, Stina
Nilsson, Gunnar H
and
Krakau, Ingvar
2007.
The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden.
BMC Family Practice,
Vol. 8,
Issue. 1,
Loyd, Michael
Rublee, Dale
and
Jacobs, Philip
2007.
An economic model of long-term use of celecoxib in patients with osteoarthritis.
BMC Gastroenterology,
Vol. 7,
Issue. 1,
Medin, Jennie
Nordlund, Anders
and
Ekberg, Kerstin
2007.
Sick leave, disability pension and health-care-seeking behaviour prior to stroke, among people aged 30–65: A case–control study.
Brain Injury,
Vol. 21,
Issue. 5,
p.
457.
Björkdahl, Ann
and
Sunnerhagen, Katharina Stibrant
2007.
Process skill rather than motor skill seems to be a predictor of costs for rehabilitation after a stroke in working age; a longitudinal study with a 1 year follow up post discharge.
BMC Health Services Research,
Vol. 7,
Issue. 1,
Hofgren, C.
Björkdahl, A.
Esbjörnsson, E.
and
Stibrant-Sunnerhagen, K.
2007.
Recovery after stroke: cognition, ADL function and return to work.
Acta Neurologica Scandinavica,
Vol. 115,
Issue. 2,
p.
73.
Brüggenjürgen, Bernd
Rossnagel, Karin
Roll, Stephanie
Andersson, Fredrik L.
Selim, Dagmar
Müller-Nordhorn, Jacqueline
Nolte, Christian H.
Jungehülsing, Gerhard J.
Villringer, Arno
and
Willich, Stefan N.
2007.
The Impact of Atrial Fibrillation on the Cost of Stroke: The Berlin Acute Stroke Study.
Value in Health,
Vol. 10,
Issue. 2,
p.
137.
Ghatnekar, Ola
and
Glader, Eva-Lotta
2008.
The Effect of Atrial Fibrillation on Stroke-Related Inpatient Costs in Sweden: A 3-Year Analysis of Registry Incidence Data from 2001.
Value in Health,
Vol. 11,
Issue. 5,
p.
862.
2008.
Stroke.
p.
903.
Ekman, M
Bienfait-Beuzon, C
and
Jackson, J
2008.
Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden.
Journal of Human Hypertension,
Vol. 22,
Issue. 12,
p.
845.